Sinolink: The end of year centralized purchasing expectations are gradually being cleared, and the pharmaceutical sector行情 is expected to gradually start.

The pharmaceutical Sector is currently in a process of a triple reversal in performance, policies, and funding, with full confidence in the recovery of revenue profit growth and market resurgence of listed companies in the Sector by 2025.

Zhitong FinanceDec 16 14:21

WUXI XDC (2268.HK): Legislative anxiety eased, performance expected to soar in 2024-2026.

On December 8, Peking time, the USA Congress meeting released the final text of the National Defense Authorization Act (NDAA) for fiscal year 2025, which did not include content related to the Biosafety Act.

HTSCDec 11 07:17 · Researches

Honk Kong Market Overview | All three major indices fell, with the Technology Index down over 1%; domestic property stocks and China-Affiliated Brokerage stocks declined, with SenseTime leading the decline in Network Technology stocks, down over 13%; Mao

Network technology stocks generally fell, SenseTime-W dropped 13.51%, Kuaishou-W fell 2.68%; most apple supplier stocks declined, Cowell fell 5.59%, BYD Electronics dropped 3.73%; most biotechnology stocks decreased, Jingtai Holdings-P fell 7.68%, beigene dropped 5.68%;

Futu NewsDec 10 16:26

Express News | Shanghai aims to nurture around 10 internationally competitive listed companies in key industries such as integrated circuits, biomedical, and new materials by 2027, forming a merger and acquisition trade scale of 300 billion yuan.

BreakingsDec 10 15:15

Morgans raised the target price of Wuxi XDC (02268.HK) to 34.8 yuan and adjusted the earnings forecast.

Morgan Stanley updated its revenue forecast for Wuxi XDC (02268.HK) for this year to 2026, estimating growth rates of 7%, 3.2%, and 1%, leading to revenues of 3.6 billion yuan, 4.8 billion yuan, and 6.7 billion yuan respectively, with a compound annual growth rate of 46.6% from 2023 to 2026. This is mainly due to the benefits of new projects exceeding expectations, along with smooth progress on existing projects. The bank expects the company's adjusted net profit forecast for this year to 2026 to be raised by 13.9%, 5.9%, and 3.3%, resulting in profits of 1 billion yuan, 1.3 billion yuan, and 1.7 billion yuan respectively, with an annual average from 2023 to 2026.

AASTOCKSDec 10 09:39

Hong Kong Market Quick Look | Hong Kong stocks soared at the end of the trading session, with the tech index rising over 4%, and Meituan up nearly 6%; domestic property stocks and china-affiliated brokerage stocks surged significantly, with sunac rising o

The Hong Kong stock market significantly surged in the final hours, with the tech index rising over 4%, leading the gains. Most network technology stocks increased, with SenseTime rising 8.19% and netease up 6.04%; apple suppliers saw widespread increases, with BYD Electronics rising 9.29% and q tech up 6.84%; securities and brokerage stocks also climbed, with china merchants increasing by 13.65% and everbright rising 7.82%;

Futu NewsDec 9 16:26